Background
The COVID-19 pandemic has caused major disruptions to healthcare globally, potentially affecting the delivery of HIV care and prevention services. Using data from the National COVID Cohort Collaborative (N3C), this study aimed to provide a comprehensive analysis of HIV testing rates and trends before, during, and after the COVID-19 pandemic, highlighting geographic and racial/ethnic variations.
Methods
We employed an interrupted time series analysis using segmented linear regression models to examine the effects of the COVID-19 pandemic on monthly HIV testing rates using data from 16 million patients across 66 clinical sites obtained from the N3C, 01/2018-12/2022. A three-phase model assessed pre-pandemic (01/2018–02/2020), early pandemic (03/2020–08/2020), and late pandemic HIV testing rates (09/2020–12/2022), calculated as any HIV screening lab per calendar month per individuals with a visit recorded that month, alongside counterfactual projections estimating testing rates. We conducted subgroup analysis by three racial/ethnic groups (White/others, Black/non-Latine, and Latine) and four geographic regions (Northeast, South, West and Midwest).
Results
HIV testing rates were relatively stable during the pre-pandemic, averaging around 45 tests per 10,000 people, with variations marked by racial/ethnic groups and regions. During the early pandemic, Black/non-Latine individuals in the Northeast experienced the most significant declines in testing, with 43.57 fewer tests per 10,000 people (95% CI: -61.384 to -25.756) . In contrast, White/Others individuals in the Midwest saw one of the smallest declines of 7.642 tests/10,000 people (95% CI: -11.205 to -4.080) during the same period (Figure 1). Although most groups and regions showed recovered HIV testing rates in the late pandemic period, Latine individuals in the Northeast continued to decline from around 140 to 105.
Conclusions
Our findings suggest that the COVID-19 pandemic significantly–but differentially–disrupted HIV testing services across the U.S., exacerbating pre-existing racial/ethnic and regional disparities. The results underscore the need for ongoing efforts to mitigate healthcare inequities and improve access to HIV testing, especially in regions and communities that were most affected by the dual epidemics.
Table or Figure
![]()